Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1834, Issue 12, 2013, Pages 2630-2639

  Hosoya, Noriyuki ^a,b   Sakumoto, Marimu ^a   Nakamura, Yukiko ^a   Narisawa, Takafumi ^b   Bilim, Vladimir ^b   Motoyama, Teiichi ^b   Tomita, Yoshihiko ^b   Kondo, Tadashi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

2D DIGE; N myc downstream regulated gene 1 protein; Prognostic tissue biomarker; Renal cell carcinoma

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; IRON CHELATING AGENT; MEMBRANE PROTEIN; N MYC DOWNSTREAM REGULATED GENE 1 PROTEIN; PROTEIN P53; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SMALL INTERFERING RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL ASSAY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

EID: 84885339608     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2013.08.009     Document Type: Article

References (43)

1. B.I. Rini, S.C. Campbell, and B. Escudier Renal cell carcinoma Lancet 373 2009 1119 1132
2. R.J. Motzer, and P. Russo Systemic therapy for renal cell carcinoma J. Urol. 163 2000 408 417 (Pubitemid 30060482)
3. N. Rioux-Leclercq, P.I. Karakiewicz, Q.D. Trinh, V. Ficarra, L. Cindolo, A. de la Taille, J. Tostain, R. Zigeuner, A. Mejean, and J.J. Patard Prognostic ability of simplified nuclear grading of renal cell carcinoma Cancer 109 2007 868 874 (Pubitemid 46333528)
4. R. Veeratterapillay, R. Simren, A. El-Sherif, M.I. Johnson, N. Soomro, and R. Heer Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England J. Clin. Pathol. 65 2012 367 371
5. A.M. Molina, and R.J. Motzer Clinical practice guidelines for the treatment of metastatic renal cell carcinoma: today and tomorrow Oncologist 16 Suppl. 2 2011 45 50
6. R.J. Motzer, M. Mazumdar, J. Bacik, W. Berg, A. Amsterdam, and J. Ferrara Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma J. Clin. Oncol. 17 1999 2530 2540 (Pubitemid 29368255)
7. E. Arai, S. Wakai-Ushijima, H. Fujimoto, F. Hosoda, T. Shibata, T. Kondo, S. Yokoi, I. Imoto, J. Inazawa, S. Hirohashi, and Y. Kanai Genome-wide DNA methylation profiles in renal tumors of various histological subtypes and non-tumorous renal tissues Pathobiology 78 2011 1 9
8. E. Arai, S. Chiku, T. Mori, M. Gotoh, T. Nakagawa, H. Fujimoto, and Y. Kanai Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas Carcinogenesis 33 2012 1487 1493
9. A.R. Brannon, S.M. Haake, K.E. Hacker, R.S. Pruthi, E.M. Wallen, M.E. Nielsen, and W.K. Rathmell Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology Eur. Urol. 61 2012 258 268
10. E.C. Nelson, C.P. Evans, and P.N. Lara Jr. Renal cell carcinoma: current status and emerging therapies Cancer Treat. Rev. 33 2007 299 313 (Pubitemid 46767941)
11. J. Akiba, Y. Murakami, M. Noda, K. Watari, S. Ogasawara, T. Yoshida, A. Kawahara, S. Sanada, M. Yasumoto, R. Yamaguchi, M. Kage, M. Kuwano, M. Ono, and H. Yano N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase Cancer Lett. 310 2011 25 34
12. S. Bandyopadhyay, S.K. Pai, S.C. Gross, S. Hirota, S. Hosobe, K. Miura, K. Saito, T. Commes, S. Hayashi, M. Watabe, and K. Watabe The Drg-1 gene suppresses tumor metastasis in prostate cancer Cancer Res. 63 2003 1731 1736 (Pubitemid 36460828)
13. Y. Maruyama, M. Ono, A. Kawahara, T. Yokoyama, Y. Basaki, M. Kage, S. Aoyagi, H. Kinoshita, and M. Kuwano Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis Cancer Res. 66 2006 6233 6242
14. D. Machin, M. Campbell, P. Fayers, and A. Pinol Comparing two survival curves Sample size tables for clinical studies 1990 174 253 (Oxford)
15. M. Unlu, M.E. Morgan, and J.S. Minden Difference gel electrophoresis: a single gel method for detecting changes in protein extracts Electrophoresis 18 1997 2071 2077 (Pubitemid 27501267)
16. T. Kondo, and S. Hirohashi Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics Nat. Protoc. 1 2007 2940 2956
17. M.K. Moore, and S.M. Viselli Staining and quantification of proteins transferred to polyvinylidene fluoride membranes Anal. Biochem. 279 2000 241 242 (Pubitemid 30165012)
18. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J. Am. Stat. Assoc. 53 1958 457 481
19. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother. Rep. 50 1966 163 170
20. D.R. Cox Regression models and life-tables J. R. Stat. Soc. 34 1972 187 220
21. Student On the error of counting with a haemacytometer Biometrika 5 1907 351 360
22. H. Cangul, K. Salnikow, H. Yee, D. Zagzag, T. Commes, and M. Costa Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis Cell Biol. Toxicol. 18 2002 87 96 (Pubitemid 34467941)
23. N.T. Le, and D.R. Richardson Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation Blood 104 2004 2967 2975 (Pubitemid 39434989)
24. B. Strzelczyk, A. Szulc, R. Rzepko, A. Kitowska, J. Skokowski, A. Szutowicz, and T. Pawelczyk Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion Ann. Surg. Oncol. 16 2009 1287 1294
25. B. Sun, D. Chu, W. Li, X. Chu, Y. Li, D. Wei, and H. Li Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients J. Neurooncol 94 2009 213 219
26. S. Fukahori, H. Yano, M. Tsuneoka, Y. Tanaka, M. Yagi, M. Kuwano, T. Tajiri, T. Taguchi, M. Tsuneyoshi, and M. Kojiro Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma J. Pediatr. Surg. 42 2007 1831 1840 (Pubitemid 350088841)
27. K. Azuma, A. Kawahara, S. Hattori, T. Taira, J. Tsurutani, K. Watari, T. Shibata, Y. Murakami, S. Takamori, M. Ono, H. Izumi, M. Kage, T. Yanagawa, K. Nakagawa, T. Hoshino, and M. Kuwano NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer J. Thorac. Oncol. 7 2012 779 789
28. J. Cheng, H.Y. Xie, X. Xu, J. Wu, X. Wei, R. Su, W. Zhang, Z. Lv, S. Zheng, and L. Zhou NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma Cancer Lett. 310 2011 35 45
29. M.S. Chua, H. Sun, S.T. Cheung, V. Mason, J. Higgins, D.T. Ross, S.T. Fan, and S. So Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma Mod. Pathol. 20 2007 76 83 (Pubitemid 44967952)
30. A. Kawahara, J. Akiba, S. Hattori, T. Yamaguchi, H. Abe, T. Taira, H. Ureshino, Y. Murakami, K. Watari, K. Koufuji, K. Shirouzu, M. Kuwano, M. Ono, and M. Kage Nuclear expression of N-myc downstream regulated gene 1/Ca(2 +)-associated protein 43 is closely correlated with tumor angiogenesis and poor survival in patients with gastric cancer Exp. Ther. Med. 2 2011 471 479
31. S. Nishio, K. Ushijima, N. Tsuda, S. Takemoto, K. Kawano, T. Yamaguchi, N. Nishida, T. Kakuma, H. Tsuda, T. Kasamatsu, Y. Sasajima, M. Kage, M. Kuwano, and T. Kamura Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma Cancer Lett. 264 2008 36 43
32. E. Shaw, L.A. McCue, C.E. Lawrence, and J.S. Dordick Identification of a novel class in the alpha/beta hydrolase fold superfamily: the N-myc differentiation-related proteins Proteins 47 2002 163 168 (Pubitemid 34263330)
33. J. Hwang, Y. Kim, H.B. Kang, L. Jaroszewski, A.M. Deacon, H. Lee, W.C. Choi, K.J. Kim, C.H. Kim, B.S. Kang, J.O. Lee, T.K. Oh, J.W. Kim, I.A. Wilson, and M.H. Kim Crystal structure of the human N-Myc downstream-regulated gene 2 protein provides insight into its role as a tumor suppressor J. Biol. Chem. 286 2011 12450 12460
34. J. Li, and L. Kretzner The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc Mol. Cell. Biochem. 250 2003 91 105 (Pubitemid 37045727)
35. S. Bandyopadhyay, S.K. Pai, S. Hirota, S. Hosobe, T. Tsukada, K. Miura, Y. Takano, K. Saito, T. Commes, D. Piquemal, M. Watabe, S. Gross, Y. Wang, J. Huggenvik, and K. Watabe PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer Cancer Res. 64 2004 7655 7660 (Pubitemid 39446890)
36. S. Stein, E.K. Thomas, B. Herzog, M.D. Westfall, J.V. Rocheleau, R.S. Jackson II, M. Wang, and P. Liang NDRG1 is necessary for p53-dependent apoptosis J. Biol. Chem. 279 2004 48930 48940 (Pubitemid 39625774)
37. Z. Kovacevic, S. Sivagurunathan, H. Mangs, S. Chikhani, D. Zhang, and D.R. Richardson The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms Carcinogenesis 32 2011 732 740
38. Z. Chen, D. Zhang, F. Yue, M. Zheng, Z. Kovacevic, and D.R. Richardson The iron chelators Dp44mT and DFO inhibit TGF-beta-induced epithelial- mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1) J. Biol. Chem. 287 2012 17016 17028
39. D.C. Adamson, T.J. Cummings, and A.H. Friedman Malignant peripheral nerve sheath tumor of the spine after radiation therapy for Hodgkin's lymphoma Clin. Neuropathol. 23 2004 245 255 (Pubitemid 39222717)
40. W. Liu, F. Xing, M. Iiizumi-Gairani, H. Okuda, M. Watabe, S.K. Pai, P.R. Pandey, S. Hirota, A. Kobayashi, Y.Y. Mo, K. Fukuda, Y. Li, and K. Watabe N-myc downstream regulated gene 1 modulates Wnt-beta-catenin signalling and pleiotropically suppresses metastasis EMBO Mol. Med. 4 2012 93 108
41. M. Whitnall, J. Howard, P. Ponka, and D.R. Richardson A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics Proc. Natl. Acad. Sci. U. S. A. 103 2006 14901 14906 (Pubitemid 44527826)
42. K.M. Dixon, G.Y. Lui, Z. Kovacevic, D. Zhang, M. Yao, Z. Chen, Q. Dong, S.J. Assinder, and D.R. Richardson Dp44mT targets the AKT, TGF-beta and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells Br. J. Cancer 2013
43. A. Fujita, H. Yamamoto, M. Imamura, N. Nakamura, Y. Maehara, M. Tsuneyoshi, and Y. Oda Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach Virchows Arch. 460 2012 163 169